|
⚲
|
| Keyboard |
| Reynolds Donald Rogers
✚
|
|
|---|---|
| CIK # | 0001687930 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001687930] | |
| 4 | [0001687930] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Reynolds Donald Rogers | |
| Mateon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mateon Therapeutics Inc MATN
Stock Option (Right to Buy) · derivative
|
2018-06-20 | Grant | 258,171 | $0.00 | |
|
Mateon Therapeutics Inc MATN
Common Stock
|
2018-04-12 | Buy | 250,000 | ||
|
Mateon Therapeutics Inc MATN
Common Stock B Warrants (Right to Buy) · derivative
|
2018-04-12 | Buy | 125,000 | ||
|
Mateon Therapeutics Inc MATN
Common Stock A Warrants (Right to Buy) · derivative
|
2018-04-12 | Buy | 125,000 | ||
|
Mateon Therapeutics Inc MATN
Stock Option (Right to Buy) · derivative
|
2017-06-09 | Grant | 121,483 | $0.00 | |
|
Mateon Therapeutics Inc MATN
Common Stock, $.01 par value per share
|
2016-12-16 | Buy | 12,700 | $0.34 | 4,318 |
|
Mateon Therapeutics Inc MATN
Common Stock, $.01 par value per share
|
2016-12-16 | Buy | 9,950 | $0.36 | 3,582 |
|
Mateon Therapeutics Inc MATN
Common Stock, $.01 par value per share
|
2016-12-16 | Buy | 7,350 | $0.35 | 2,572 |
|
Mateon Therapeutics Inc MATN
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Grant | 135,612 | $0.00 |